Document Detail


Preparations of lymphotoxin induce resistance to their own cytotoxic effect.
MedLine Citation:
PMID:  6609199     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Preparations of human lymphotoxins (LT) were effectively cytotoxic to HeLa cells when applied in the presence of cycloheximide (CHI). In the absence of CHI, however, they failed to cause any cell death. Moreover, LT applied in the absence of CHI induced resistance that was reflected in decreased vulnerability to subsequent incubation with LT in the presence of CHI. This induction of resistance to LT, in treating cells with preparations of LT, was quite rapid, reaching its maximal extent within 2 hr of LT application. It could also be observed in cells of other cultured human lines besides HeLa (SV80 and WISH), and the range of LT concentrations at which it was observed was similar to that at which death of cells was induced by LT in the presence of CHI. In fractionating LT preparations on DEAE cellulose, the resistance inducing activity appeared to co-purify with the cytotoxic activity, suggesting that both activities reside in the same molecule. We suggest that LT, or some lymphokines that are formed by lymphocytes concomitantly with the formation of LT, can induce cellular mechanisms that interfere with the cytotoxic activity of LT and that CHI makes the cell sensitive to the cytotoxicity of LT by reducing the activity of these protective mechanisms. This kind of negative feedback regulation in the function of LT might contribute to selectivity in their action.
Authors:
D Wallach
Related Documents :
8922269 - Inhibition of colony formation of hela cells by naturally occurring and synthetic agents.
1786199 - Growth inhibitory effect of bestatin on choriocarcinoma cell lines in vitro.
18330899 - Myh9-sirna and myh9 mutant alleles: expression in cultured cell lines and their effects...
809479 - Comparative susceptibility of eleven mammalian cell lines to infection with trachoma or...
22361669 - Autophagy prolongs survival after nfκb inhibition in b-cell lymphomas.
11570889 - Two distinctive cell binding patterns by vacuolating toxin fused with glutathione s-tra...
16988839 - Primary hepatic lymphoma with spindle cell components: a case report.
15827669 - Mesenchymal stem cells in musculoskeletal tissue engineering: a review of recent advanc...
6202479 - Detoxification of chlordecone poisoned rats with chlorella and chlorella derived sporop...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of immunology (Baltimore, Md. : 1950)     Volume:  132     ISSN:  0022-1767     ISO Abbreviation:  J. Immunol.     Publication Date:  1984 May 
Date Detail:
Created Date:  1984-06-01     Completed Date:  1984-06-01     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  2985117R     Medline TA:  J Immunol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2464-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chromatography, DEAE-Cellulose
Cycloheximide / pharmacology
Cytotoxicity, Immunologic* / drug effects
Hela Cells / drug effects,  immunology
Humans
Immunity, Cellular / drug effects
Immunity, Innate / drug effects
Kinetics
Lymphotoxin-alpha / isolation & purification,  pharmacology*
Chemical
Reg. No./Substance:
0/Lymphotoxin-alpha; 66-81-9/Cycloheximide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Partial purification and characterization of a BCGFII from EL4 culture supernatants.
Next Document:  Lymphocyte modulation of fibroblast function in vitro: stimulation and inhibition of collagen produc...